trial · primary record
Hydroxychloroquine (HCQ)
Parkinson&Amp;#39;s Disease
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-09 |
| Primary endpoint | Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 |
| Registry ID | NCT06816810 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:02.862Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06816810
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.